Radiological Associates of Sacramento
Radiation Oncology
Dr. Dwight R. Stickney, MD
|
|
Give Review
Dr. Dwight R. Stickney is an expert in the field of Radiation Oncology. He attended The Ohio State University College of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Dwight R. Stickney is a published doctor and has 33 publications published. The lastest was: 'Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.' He is registered with Medicare.
Publications
- An anti-inflammatory sterol decreases obesity-related inflammation-induced insulin resistance and metabolic dysregulation.
- A synthetic anti-inflammatory sterol improves insulin sensitivity in insulin-resistant obese impaired glucose tolerance subjects.
- Phase I and Phase II clinical trials of androst-5-ene-3β,7β,17β-triol.
- Studies of the pharmacology of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol, a synthetic anti-inflammatory androstene.
- Safety and activity of the immune modulator HE2000 on the incidence of tuberculosis and other opportunistic infections in AIDS patients.
- Reduction of parasite levels in patients with uncomplicated malaria by treatment with HE2000.
- Rate of heating as a determinant of hyperthermic cytotoxicity.
- 17?-alkynyl 3?, 17?-androstanediol non-clinical and clinical pharmacology, pharmacokinetics and metabolism.
- T cell receptor delta gene repertoire and diversity of intestinal intraepithelial lymphocytes in athymic mice.
- HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.
- HE3286: a novel synthetic steroid as an oral treatment for autoimmune disease.
- Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
- 16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs.
- Inhibition of androstenediol-dependent LNCaP tumour growth by 17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol (HE3235).
- Enhancement of monoclonal antibody binding to melanoma with single dose radiation or hyperthermia.
- Suppression of tumor growth and enhancement of immune status with high levels of dietary vitamin B6 in BALB/c mice.
- Effect of pyridoxine and pyridoxal on the in vitro growth of human malignant melanoma.
- Evaluation of cancer patient leukocyte responses in the presence of physiologic and pharmacologic pyridoxine and pyridoxal levels.
- Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
- Enhancement of immune status by high levels of dietary vitamin B-6 without growth inhibition of human malignant melanoma in athymic nude mice.
- Organization of a monoclonal antibody clinical unit.
- Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617.
- Changes in leucocyte populations following murine bifunctional antibody infusion in colon cancer patients.
- Hyperthermia enhances localization of 111In-labeled hapten to bifunctional antibody in human colon tumor xenografts.
- Effects of radiolabelled monoclonal antibody infusion on blood leukocytes in cancer patients.
- Bifunctional antibody: a binary radiopharmaceutical delivery system for imaging colorectal carcinoma.
- Biologic response modifiers: therapeutic approaches to lymphoproliferative diseases.
- Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, d...
- 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression.
- Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
- 5-androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression.
- Preliminary clinical findings on NEUMUNE as a potential treatment for acute radiation syndrome.
Schools
Ohio State University College of Medicine
University Mo
Loma Linda University Med Center
Duke Hospital
Doctors Specialties
- Hematology
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Loma Linda University -
Duke University Hospital -
University of Missouri-Columbia -
The Ohio State University College of Medicine
Hospital
-
Sutter Roseville Medical Center
Drug Facts
| NPI NUMBER | 1225296676 | |
| NPPES Provider LastName | STICKNEY | |
| NPPES Provider FirstName | DWIGHT | |
| NPPES Provider ZIPCode | 957469425 | |
| NPPES Provider State | CA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 39.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225296676 |
| Last Name Of The Provider | STICKNEY |
| First Name Of The Provider | DWIGHT |
| View All |